Association of the triglyceride-glucose-body mass index with all-cause mortality in critically ill patients with hemorrhagic stroke: a retrospective cohort study from the MIMIC-IV database

Neurosurg Rev. 2026 Jan 24;49(1):158. doi: 10.1007/s10143-025-04095-8.ABSTRACTHemorrhagic stroke (HS) is a severe condition with high mortality. Identifying high-risk patients for early intervention remains challenging. The triglyceride-glucose-body mass index (TyG-BMI), a simple and cost-effective

Z ZhenKun Xiao

Effect of prior antiplatelet therapy on recurrence in patients with acute cerebral ischaemia: data from the triple antiplatelets for reducing dependency after ischaemic stroke (TARDIS) randomised trial

Neurol Sci. 2026 Jan 24;47(2):191. doi: 10.1007/s10072-025-08625-6.ABSTRACTBACKGROUND: Data regarding management of patients already on an antiplatelet when presenting with an ischaemic stroke or transient ischaemic attack (TIA) are limited. This secondary analysis of the triple antiplatelets for re

J Jason P Appleton

Therapeutic Hypothermia Alleviates Hydrocephalus and Neurological Dysfunction Post Intraventricular Hemorrhage by Enhancing Drainage of Glymphatic-Meningeal Lymphatic-Deep Cervical Lymphatic System

CNS Neurosci Ther. 2026 Jan;32(1):e70740. doi: 10.1002/cns.70740.ABSTRACTAIMS: Intraventricular hemorrhage (IVH) has a high mortality and disability rate and poses significant clinical challenges, which often leads to hydrocephalus and neurological dysfunction. Emerging evidence implicates dysfuncti

Y Yijian Yang

International Clinical Evidence-based Guideline for Kleefstra Syndrome

Genet Med. 2026 Jan 20:102070. doi: 10.1016/j.gim.2026.102070. Online ahead of print.ABSTRACTKleefstra syndrome (KLEFS1) is a rare monogenic neurodevelopmental disorder (mNDD) with multisystem involvement, caused by disruption of EHMT1 function, resulting in significant burden on affected individual

A Arianne Bouman